Cibc World Market Inc. Invests $3.57 Million in IDEX Corporation $IEX

Cibc World Market Inc. purchased a new position in IDEX Corporation (NYSE:IEX) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 15,712 shares of the industrial products company’s stock, valued at approximately $3,566,000.

A number of other hedge funds have also recently bought and sold shares of IEX. Empowered Funds LLC raised its holdings in IDEX by 3.4% in the first quarter. Empowered Funds LLC now owns 1,646 shares of the industrial products company’s stock valued at $298,000 after acquiring an additional 54 shares in the last quarter. EverSource Wealth Advisors LLC lifted its position in shares of IDEX by 41.1% during the second quarter. EverSource Wealth Advisors LLC now owns 1,043 shares of the industrial products company’s stock worth $183,000 after purchasing an additional 304 shares during the last quarter. Cresset Asset Management LLC bought a new position in shares of IDEX during the second quarter worth about $219,000. Cerity Partners LLC grew its stake in IDEX by 23.9% in the second quarter. Cerity Partners LLC now owns 18,658 shares of the industrial products company’s stock worth $3,276,000 after purchasing an additional 3,604 shares in the last quarter. Finally, Daiwa Securities Group Inc. grew its stake in IDEX by 4.0% in the second quarter. Daiwa Securities Group Inc. now owns 13,513 shares of the industrial products company’s stock worth $2,373,000 after purchasing an additional 518 shares in the last quarter. Institutional investors and hedge funds own 97.96% of the company’s stock.

Insider Transactions at IDEX

In related news, CAO Lisa M. Anderson sold 385 shares of the business’s stock in a transaction that occurred on Wednesday, August 12th. The stock was sold at an average price of $238.59, for a total transaction of $91,857.15. Following the completion of the transaction, the chief accounting officer owned 4,327 shares in the company, valued at $1,032,378.93. The trade was a 8.17% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.50% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the company. Citigroup upped their price objective on IDEX from $252.00 to $269.00 and gave the company a “buy” rating in a research note on Thursday, July 30th. TD Cowen lifted their target price on IDEX from $260.00 to $275.00 and gave the stock a “buy” rating in a research report on Thursday, July 30th. Robert W. Baird set a $257.00 price target on IDEX in a report on Thursday, April 30th. Stifel Nicolaus upped their price target on IDEX from $257.00 to $268.00 and gave the company a “buy” rating in a research report on Thursday, July 30th. Finally, DA Davidson raised their price objective on IDEX from $230.00 to $240.00 and gave the stock a “neutral” rating in a research note on Thursday, August 6th. Eight investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, IDEX has a consensus rating of “Moderate Buy” and a consensus price target of $260.80.

IDEX Price Performance

Shares of NYSE:IEX opened at $234.91 on Thursday. The company has a market cap of $17.32 billion, a PE ratio of 33.80, a P/E/G ratio of 2.17 and a beta of 0.98. IDEX Corporation has a fifty-two week low of $158.19 and a fifty-two week high of $243.80. The firm has a 50-day simple moving average of $228.47 and a 200 day simple moving average of $213.48. The company has a quick ratio of 2.15, a current ratio of 3.05 and a debt-to-equity ratio of 0.46.

IDEX (NYSE:IEX) last issued its earnings results on Wednesday, July 29th. The industrial products company reported $2.32 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.11 by $0.21. IDEX had a net margin of 14.49% and a return on equity of 15.69%. The firm had revenue of $920.60 million for the quarter, compared to analysts’ expectations of $905.38 million. During the same quarter last year, the company posted $2.07 earnings per share. IDEX’s revenue was up 6.4% on a year-over-year basis. IDEX has set its FY 2026 guidance at 8.700-8.850 EPS and its Q3 2026 guidance at 2.200-2.250 EPS. On average, sell-side analysts anticipate that IDEX Corporation will post 8.82 EPS for the current year.

IDEX Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, July 24th. Investors of record on Monday, July 6th were issued a $0.73 dividend. The ex-dividend date of this dividend was Monday, July 6th. This represents a $2.92 annualized dividend and a dividend yield of 1.2%. IDEX’s dividend payout ratio (DPR) is 42.01%.

IDEX News Summary

Here are the key news stories impacting IDEX this week:

• Positive Sentiment: Zacks increased its FY2026 EPS estimate to $8.71 from $8.70, Q4 2026 to $2.20 from $2.18, and Q1 2027 to $2.12 from $2.11.
• Positive Sentiment: Longer-term estimates also improved: FY2027 EPS rose to $9.26 from $9.21, Q4 2027 to $2.42 from $2.38, Q1 2028 to $2.38 from $2.36, and FY2028 to $10.54 from $10.45. The revisions imply continued earnings growth, although the increases were relatively small.
• Positive Sentiment: The revised FY2026 estimate of $8.71 remains close to the broader analyst consensus of $8.82. IDEX’s latest reported quarter also showed earnings and revenue ahead of expectations, with EPS of $2.32 and revenue of $920.6 million, up 6.4% year over year.
• Neutral Sentiment: The six Zacks updates largely repeat the same forecast changes rather than representing separate fundamental developments. Investors may view them as supportive, but the limited size of the revisions may constrain their impact.
• Neutral Sentiment: IDEX shares have increased and are trading near the upper end of their 52-week range, above both their 50-day and 200-day moving averages. With a market capitalization of approximately $17.3 billion and a forward-looking valuation near 27 times earnings, further gains may depend on the company converting the raised forecasts into actual results.
• Neutral Sentiment: A separate report concerns IDEX Biometrics ASA (OTC: IDXAF), which granted incentive subscription rights to two senior employees. That company is unrelated to IDEX Corporation and should not affect IEX shares. IDEX Biometrics executive incentive rights announcement

About IDEX

IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company’s core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.

Operations at IDEX are organized into three principal segments.